Since GLIS2 has a high homology of DNA-binding domain with other GLI proteins, GANT61 may target CBFA2T3:GLIS2 fusion in pediatric AML (Masetti et al., 2017; Lau et al., 2019). This evidence concerns the gene CBFA2T3 and acute myeloid leukemia.